Violation Tracker Individual Record
Date:August 7, 2018
Primary Offense:False Claims Act and related
Secondary Offense:off-label or unapproved promotion of medical products
AstraZeneca agreed to pay $110 million to the state of Texas to settle lawsuits alleging that the company falsely and misleadingly marketed two of its drugs in violation of the Texas Medicaid Fraud Prevention Act.
Level of Government:state
Action Type:agency action
Agency:Texas Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:Britain
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.